
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $661.7M | $481.4M | $669.4M | $860.5M | $1.1B | |
Revenue Growth (YoY) | -12.09% | -27.25% | 39.07% | 28.54% | 25.53% | |
Cost of Revenues | $603.8M | $480.6M | $612.2M | $764.9M | $971.9M | |
Gross Profit | $57.9M | $749K | $57.2M | $95.6M | $108.2M | |
Gross Profit Margin | 8.75% | 0.16% | 8.55% | 11.11% | 10.02% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.1M | $3.5M | $3.6M | $7.6M | $14.6M | |
Other Inc / (Exp) | -$40.8M | -- | -- | -- | -$12.2M | |
Operating Expenses | $3.1M | $3.5M | $3.6M | $7.6M | $14.6M | |
Operating Income | $54.8M | -$2.7M | $53.6M | $88M | $93.6M | |
Net Interest Expenses | $13.5M | $12.1M | $17.9M | $31.1M | $34.9M | |
EBT. Incl. Unusual Items | $427K | -$14.8M | $35.7M | $56.9M | $46.5M | |
Earnings of Discontinued Ops. | -- | $19M | $1.4M | -$4M | -$21.2M | |
Income Tax Expense | $5.6M | -$3.8M | $9.1M | $13.8M | $10M | |
Net Income to Company | -$5.2M | $8M | $28.1M | $39.1M | $15.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.2M | $8M | $28.1M | $39.1M | $15.3M | |
Basic EPS (Cont. Ops) | -$0.47 | $0.63 | $2.20 | $2.77 | $0.86 | |
Diluted EPS (Cont. Ops) | -$0.47 | $0.63 | $2.19 | $2.76 | $0.85 | |
Weighted Average Basic Share | $11M | $12.6M | $12.8M | $14.1M | $17.9M | |
Weighted Average Diluted Share | $11M | $12.6M | $12.8M | $14.2M | $18M | |
EBITDA | $38.1M | $21.9M | $78.2M | $111.4M | $110.2M | |
EBIT | $13.9M | -$2.7M | $53.6M | $88M | $81.4M | |
Revenue (Reported) | $661.7M | $481.4M | $669.4M | $860.5M | $1.1B | |
Operating Income (Reported) | $54.8M | -$2.7M | $53.6M | $88M | $93.6M | |
Operating Income (Adjusted) | $13.9M | -$2.7M | $53.6M | $88M | $81.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $165M | $231.2M | $188.6M | $162.4M | $256M | |
Revenue Growth (YoY) | -7.01% | 40.16% | -18.45% | -13.9% | 57.68% | |
Cost of Revenues | $155.3M | $218.4M | $169.8M | $143.8M | $229.2M | |
Gross Profit | $9.6M | $12.8M | $18.8M | $18.6M | $26.8M | |
Gross Profit Margin | 5.84% | 5.54% | 9.98% | 11.44% | 10.47% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $38K | $906K | $2M | $2.9M | $2.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $38K | $906K | $2M | $2.9M | $2.3M | |
Operating Income | $9.6M | $11.9M | $16.8M | $15.6M | $24.5M | |
Net Interest Expenses | $3M | $3.6M | $6M | $9.2M | $7.9M | |
EBT. Incl. Unusual Items | $6.6M | $8.3M | $10.8M | $6.5M | $16.6M | |
Earnings of Discontinued Ops. | -- | -- | $997K | -$12.2M | -$22.9M | |
Income Tax Expense | $1.5M | $2.1M | $2.7M | $911K | $2.6M | |
Net Income to Company | $5.1M | $6.2M | $9.1M | -$6.6M | -$9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.1M | $6.2M | $9.1M | -$6.6M | -$9M | |
Basic EPS (Cont. Ops) | $0.42 | $0.49 | $0.71 | -$0.42 | -$0.43 | |
Diluted EPS (Cont. Ops) | $0.42 | $0.49 | $0.71 | -$0.42 | -$0.44 | |
Weighted Average Basic Share | $12.1M | $12.7M | $12.8M | $15.8M | $20.6M | |
Weighted Average Diluted Share | $12.2M | $12.8M | $12.9M | $15.9M | $20.7M | |
EBITDA | $15.5M | $18.3M | $23M | $21.6M | $34.4M | |
EBIT | $9.6M | $11.9M | $16.8M | $15.6M | $24.5M | |
Revenue (Reported) | $165M | $231.2M | $188.6M | $162.4M | $256M | |
Operating Income (Reported) | $9.6M | $11.9M | $16.8M | $15.6M | $24.5M | |
Operating Income (Adjusted) | $9.6M | $11.9M | $16.8M | $15.6M | $24.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $649.2M | $547.6M | $697.7M | $834.3M | $1.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $598.1M | $543.7M | $634.4M | $738.9M | $986.8M | |
Gross Profit | $51.1M | $3.9M | $63.3M | $95.4M | $107.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.9M | $4.3M | $5M | $8.5M | $13.9M | |
Other Inc / (Exp) | -$34.4M | -- | -- | -- | -$12.2M | |
Operating Expenses | $2.9M | $4.3M | $5M | $8.5M | $13.9M | |
Operating Income | $48.2M | -$394K | $58.4M | $86.9M | $94M | |
Net Interest Expenses | $13M | $12.6M | $20.3M | $34.3M | $33.7M | |
EBT. Incl. Unusual Items | $752K | -$13M | $38.1M | $52.6M | $48.1M | |
Earnings of Discontinued Ops. | -- | -- | $2.4M | -$17.2M | -$25.4M | |
Income Tax Expense | $4.1M | -$3.2M | $9.6M | $12M | $9.7M | |
Net Income to Company | -$3.4M | $9.1M | $30.9M | $23.4M | $13M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$3.4M | $9.1M | $30.9M | $23.4M | $13M | |
Basic EPS (Cont. Ops) | -$0.36 | $0.72 | $2.42 | $1.64 | $0.79 | |
Diluted EPS (Cont. Ops) | -$0.36 | $0.72 | $2.41 | $1.63 | $0.78 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $37.4M | $24.6M | $82.9M | $110M | $114.5M | |
EBIT | $13.8M | -$394K | $58.4M | $86.9M | $81.7M | |
Revenue (Reported) | $649.2M | $547.6M | $697.7M | $834.3M | $1.1B | |
Operating Income (Reported) | $48.2M | -$394K | $58.4M | $86.9M | $94M | |
Operating Income (Adjusted) | $13.8M | -$394K | $58.4M | $86.9M | $81.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $165M | $231.2M | $188.6M | $162.4M | $256M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $155.3M | $218.4M | $169.8M | $143.8M | $229.2M | |
Gross Profit | $9.6M | $12.8M | $18.8M | $18.6M | $26.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $38K | $906K | $2M | $2.9M | $2.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $38K | $906K | $2M | $2.9M | $2.3M | |
Operating Income | $9.6M | $11.9M | $16.8M | $15.6M | $24.5M | |
Net Interest Expenses | $3M | $3.6M | $6M | $9.2M | $7.9M | |
EBT. Incl. Unusual Items | $6.6M | $8.3M | $10.8M | $6.5M | $16.6M | |
Earnings of Discontinued Ops. | -- | -- | $997K | -$12.2M | -$22.9M | |
Income Tax Expense | $1.5M | $2.1M | $2.7M | $911K | $2.6M | |
Net Income to Company | $5.1M | $6.2M | $9.1M | -$6.6M | -$9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.1M | $6.2M | $9.1M | -$6.6M | -$9M | |
Basic EPS (Cont. Ops) | $0.42 | $0.49 | $0.71 | -$0.42 | -$0.43 | |
Diluted EPS (Cont. Ops) | $0.42 | $0.49 | $0.71 | -$0.42 | -$0.44 | |
Weighted Average Basic Share | $12.1M | $12.7M | $12.8M | $15.8M | $20.6M | |
Weighted Average Diluted Share | $12.2M | $12.8M | $12.9M | $15.9M | $20.7M | |
EBITDA | $15.5M | $18.3M | $23M | $21.6M | $34.4M | |
EBIT | $9.6M | $11.9M | $16.8M | $15.6M | $24.5M | |
Revenue (Reported) | $165M | $231.2M | $188.6M | $162.4M | $256M | |
Operating Income (Reported) | $9.6M | $11.9M | $16.8M | $15.6M | $24.5M | |
Operating Income (Adjusted) | $9.6M | $11.9M | $16.8M | $15.6M | $24.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $378K | $518K | $305K | $7.8M | $29M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $55.5M | $76.6M | $90.6M | $128M | $197.6M | |
Inventory | $253.4M | $322.7M | $380.4M | $500.9M | $576.3M | |
Prepaid Expenses | $5.6M | $14.6M | -- | -- | -- | |
Other Current Assets | $11.5M | $14.9M | $15.2M | $36.4M | $42M | |
Total Current Assets | $355M | $464M | $548.9M | $774M | $874.8M | |
Property Plant And Equipment | $56.9M | $69.8M | $62.1M | $86.8M | $138.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $238.1M | $248.8M | $217.3M | $351.8M | $491.5M | |
Other Intangibles | $103.6M | $108.3M | $86.6M | $114.1M | $197.3M | |
Other Long-Term Assets | $2.3M | $27.7M | $85M | $23.6M | $32.1M | |
Total Assets | $780.1M | $918.6M | $999.8M | $1.4B | $1.7B | |
Accounts Payable | $72.7M | $115.1M | $128.5M | $173M | $187.6M | |
Accrued Expenses | $2.8M | $4.5M | $6.2M | $7.3M | $16M | |
Current Portion Of Long-Term Debt | $20.4M | $14.2M | $10M | $22.5M | $30M | |
Current Portion Of Capital Lease Obligations | $4M | $6M | $3.2M | $5M | $6.9M | |
Other Current Liabilities | $5.9M | $7.4M | $61.5M | $58.9M | $14.4M | |
Total Current Liabilities | $139.2M | $180M | $224.6M | $286.9M | $281.8M | |
Long-Term Debt | $230.7M | $270.4M | $276.3M | $406.8M | $400.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $423.8M | $501.2M | $550.3M | $733.6M | $746.4M | |
Common Stock | $553K | $636K | $641K | $788K | $1M | |
Other Common Equity Adj | -$1.2M | -$176K | $5M | $2.1M | $3.1M | |
Common Equity | $356.3M | $417.3M | $449.5M | $616.7M | $988.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $356.3M | $417.3M | $449.5M | $616.7M | $988.2M | |
Total Liabilities and Equity | $780.1M | $918.6M | $999.8M | $1.4B | $1.7B | |
Cash and Short Terms | $378K | $518K | $305K | $7.8M | $29M | |
Total Debt | $251.1M | $284.6M | $286.3M | $429.3M | $430.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $347K | $498K | $532K | $10.6M | $5.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $63.6M | $84M | $113.5M | $145.4M | $169.5M | |
Inventory | $282.8M | $332M | $416.7M | $521.2M | $441.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $29.2M | $27M | $24.2M | $55.1M | $61.8M | |
Total Current Assets | $419.5M | $474.7M | $590.8M | $743.1M | $968.9M | |
Property Plant And Equipment | $60.5M | $70.5M | $82.8M | $101.7M | $116.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $238.1M | $248.8M | $253.6M | $351.1M | $423.6M | |
Other Intangibles | $105.9M | $103.5M | $90.1M | $110.7M | $191M | |
Other Long-Term Assets | $29M | $23.4M | $27.2M | $30.3M | $33.1M | |
Total Assets | $853.1M | $921M | $1B | $1.3B | $1.7B | |
Accounts Payable | $73.8M | $94.9M | $141.9M | $155.5M | $140.8M | |
Accrued Expenses | $50.9M | $46.7M | $44.3M | $36M | $46.8M | |
Current Portion Of Long-Term Debt | $21.3M | $14.2M | $10M | $30M | $5.6M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | $53M | |
Total Current Liabilities | $147.2M | $157M | $197.4M | $223.1M | $248.3M | |
Long-Term Debt | $232.2M | $289.7M | $341.9M | $451.6M | $459.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $438.8M | $497.2M | $587.1M | $724.2M | $757.2M | |
Common Stock | $635K | $638K | $644K | $792K | $1M | |
Other Common Equity Adj | -$692K | -- | $3M | $4.6M | $1.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $414.3M | $423.8M | $457.3M | $612.7M | $975.7M | |
Total Liabilities and Equity | $853.1M | $921M | $1B | $1.3B | $1.7B | |
Cash and Short Terms | $347K | $498K | $532K | $10.6M | $5.7M | |
Total Debt | $253.6M | $303.8M | $351.9M | $481.6M | $465M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.2M | $8M | $28.1M | $39.1M | $15.3M | |
Depreciation & Amoritzation | $24.1M | $24.6M | $24.6M | $23.4M | $28.8M | |
Stock-Based Compensation | $2.9M | $3.9M | $4.5M | $7.7M | $8.3M | |
Change in Accounts Receivable | $27.4M | -$15M | -$33M | -$20.8M | -$32.5M | |
Change in Inventories | -$50.2M | -$80M | -$59.1M | -$87.5M | -$31.7M | |
Cash From Operations | $35.8M | -$17.6M | $8.1M | -$21.8M | -$31M | |
Capital Expenditures | $4.4M | $10.5M | $11.2M | $18.7M | $20.7M | |
Cash Acquisitions | $19.9M | -$53.3M | -- | -$218.6M | -$243M | |
Cash From Investing | $20.2M | -$61.6M | -$2.4M | -$235.7M | -$263.7M | |
Dividends Paid (Ex Special Dividend) | -$4M | -$4.4M | -$5.1M | -$5.4M | -$7.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $433M | $491.6M | $520.2M | $844.3M | $739.2M | |
Long-Term Debt Repaid | -$452.3M | -$458.3M | -$518.3M | -$699.9M | -$739.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$33M | -$1.5M | -$3.4M | -$4M | -$2.6M | |
Cash From Financing | -$56.3M | $79.4M | -$5.7M | $265M | $315.8M | |
Beginning Cash (CF) | $734K | $378K | $518K | $478K | $7.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$356K | $140K | -$40K | $7.5M | $21.1M | |
Ending Cash (CF) | $378K | $518K | $478K | $7.9M | $29M | |
Levered Free Cash Flow | $31.3M | -$28.1M | -$3.2M | -$40.5M | -$51.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $5.1M | $6.2M | $9.1M | -$6.6M | -$9M | |
Depreciation & Amoritzation | $5.9M | $6.3M | $6.2M | $5.9M | $9.9M | |
Stock-Based Compensation | $1.4M | $1.3M | $2.1M | $2.5M | $3.5M | |
Change in Accounts Receivable | -$20.1M | -$6.7M | -$7.4M | -$16.8M | -$20.3M | |
Change in Inventories | -$28.9M | -$9.3M | -$33.2M | -$19.9M | -$6.4M | |
Cash From Operations | -$36.4M | -$18.2M | -$48.7M | -$79.1M | -$46.6M | |
Capital Expenditures | $2.1M | $1.3M | $2.8M | $7.7M | $2.9M | |
Cash Acquisitions | -$14.8M | -- | -$11.8M | $41.1M | $2.7M | |
Cash From Investing | -$16.5M | $1.4M | -$14.6M | $33.4M | -$129K | |
Dividends Paid (Ex Special Dividend) | -$997K | -$1.3M | -$1.3M | -$1.6M | -$2.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $146.4M | $112.1M | $176.8M | $211.1M | $74.5M | |
Long-Term Debt Repaid | -$144.3M | -$93M | -$111.4M | -$159.1M | -$40M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$390K | -$1M | -$1M | -$2.1M | -$4.2M | |
Cash From Financing | $52.8M | $16.8M | $63.3M | $48.3M | $28.2M | |
Beginning Cash (CF) | $378K | $518K | $478K | $7.9M | $29M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$31K | -$20K | $54K | $2.6M | -$18.5M | |
Ending Cash (CF) | $347K | $498K | $532K | $10.6M | $10.5M | |
Levered Free Cash Flow | -$38.5M | -$19.4M | -$51.5M | -$86.8M | -$49.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$3.4M | $9.1M | $30.9M | $23.4M | $13M | |
Depreciation & Amoritzation | $23.6M | $25M | $24.5M | $23.1M | $32.7M | |
Stock-Based Compensation | $3.4M | $3.8M | $5.2M | $8.2M | $9.3M | |
Change in Accounts Receivable | $9.5M | -$1.5M | -$33.7M | -$30.2M | -$36M | |
Change in Inventories | -$70.8M | -$60.4M | -$83M | -$74.2M | -$18.1M | |
Cash From Operations | -$7.4M | $591K | -$22.4M | -$52.2M | $1.4M | |
Capital Expenditures | $5.8M | $9.7M | $12.8M | $23.6M | $15.9M | |
Cash Acquisitions | -$15.6M | -$38.6M | -$11.8M | -$165.7M | -$281.4M | |
Cash From Investing | -$19.1M | -$43.8M | -$18.4M | -$187.7M | -$297.2M | |
Dividends Paid (Ex Special Dividend) | -$4M | -$4.7M | -$5.1M | -$5.7M | -$7.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $448.3M | $457.2M | $584.9M | $878.6M | $602.6M | |
Long-Term Debt Repaid | -$468.9M | -$407M | -$536.7M | -$747.6M | -$620.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.2M | -$2.1M | -$3.4M | -$5.1M | -$4.8M | |
Cash From Financing | $26.2M | $43.3M | $40.8M | $249.9M | $295.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$196K | $151K | $34K | $10M | -$61K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$13.2M | -$9.1M | -$35.2M | -$75.8M | -$14.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $5.1M | $6.2M | $9.1M | -$6.6M | -$9M | |
Depreciation & Amoritzation | $5.9M | $6.3M | $6.2M | $5.9M | $9.9M | |
Stock-Based Compensation | $1.4M | $1.3M | $2.1M | $2.5M | $3.5M | |
Change in Accounts Receivable | -$20.1M | -$6.7M | -$7.4M | -$16.8M | -$20.3M | |
Change in Inventories | -$28.9M | -$9.3M | -$33.2M | -$19.9M | -$6.4M | |
Cash From Operations | -$36.4M | -$18.2M | -$48.7M | -$79.1M | -$46.6M | |
Capital Expenditures | $2.1M | $1.3M | $2.8M | $7.7M | $2.9M | |
Cash Acquisitions | -$14.8M | -- | -$11.8M | $41.1M | $2.7M | |
Cash From Investing | -$16.5M | $1.4M | -$14.6M | $33.4M | -$129K | |
Dividends Paid (Ex Special Dividend) | -$997K | -$1.3M | -$1.3M | -$1.6M | -$2.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $146.4M | $112.1M | $176.8M | $211.1M | $74.5M | |
Long-Term Debt Repaid | -$144.3M | -$93M | -$111.4M | -$159.1M | -$40M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$390K | -$1M | -$1M | -$2.1M | -$4.2M | |
Cash From Financing | $52.8M | $16.8M | $63.3M | $48.3M | $28.2M | |
Beginning Cash (CF) | $378K | $518K | $478K | $7.9M | $29M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$31K | -$20K | $54K | $2.6M | -$18.5M | |
Ending Cash (CF) | $347K | $498K | $532K | $10.6M | $10.5M | |
Levered Free Cash Flow | -$38.5M | -$19.4M | -$51.5M | -$86.8M | -$49.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.